What this page is really about
Topic-specific operating context: Healthcare information changes unevenly. The site separates stable structural facts from policy details that require routine review. The practical question is which decision-maker, payment route, evidence threshold, or implementation setting determines whether the issue changes real behavior.
The page should therefore be read around a concrete operating question: for Source methodology, what changes in a real decision? The answer usually depends on institutional role, decision-maker, evidence threshold, payment route, implementation setting, and operational risk. These are the items a company, policymaker, investor, hospital partner, or reader should verify before turning the topic into a strategy. The most useful evidence is not a broad market statistic; it is evidence that shows where the relevant gate sits, how the gate is passed, and what happens after the gate is passed.
For U.S.-China comparison, Source methodology also needs translation across institutions. A U.S. reader may look for payer contracts, FDA status, coding, malpractice exposure, and private-provider economics. A China-facing reader may look for NMPA registration, NHSA reimbursement, public-hospital adoption, provincial procurement, local distributor capability, and policy implementation by municipal or provincial authorities. Those are not interchangeable checklists. They point to different documents, different buyers, different timelines, and different failure modes.
| Decision point | What to verify | Why it matters |
|---|---|---|
| Authority | Which regulator, payer, hospital, procurement body, or partner has decision rights for Source methodology? | Decision rights determine the first real adoption gate. |
| Evidence | What clinical, economic, technical, compliance, or operational evidence is persuasive in this setting? | Evidence that satisfies one stakeholder may be irrelevant to another. |
| Implementation | Who pays, who uses, who services, who monitors, and who bears risk after adoption? | Execution details decide whether a policy or approval becomes routine practice. |
The common failure mode is leaving the concept at the level of a dictionary definition. A stronger reading is narrower and more practical: define the patient or customer segment, name the decision-maker, state the payment route, identify the evidence threshold, and then decide whether the topic creates a near-term action, a diligence question, or a longer-term market signal.
Direct answer
Source methodology exists to keep the site reliable as it grows. The subject matter spans stable institutional structures and fast-changing policy details, so the site needs explicit rules for sourcing, maintenance rhythm, and page maintenance.
Why it matters
Healthcare systems are not static, but not all claims change at the same rate. A page explaining why Chinese hospitals are central to the delivery system can remain useful longer than a page describing a current reimbursement rule or regulatory pathway.
The site therefore separates pages into stable explainers, review-sensitive regulation and payment pages, historical archive pages, and Chinese-language access pages. Each category has different review expectations.
Method
| Content type | Preferred sources | Maintenance rule |
|---|---|---|
| System explainers | Official agencies, academic reviews, international datasets | Annual |
| Regulation and payment | Official regulator, payer, and legal sources | Six months |
| Archive pages | Preserved historical site material | No routine review except link maintenance |
| Chinese-language pages | English canonical page plus terminology review | Annual or when canonical changes |
Practical rule
When a page makes a current policy claim, it should identify the source family and maintenance marker. When a page explains a stable concept, it should still include source notes, but the review burden is lower.